In October 2024, aspirin prices in North America experienced a notable decline, primarily driven by reduced demand from end-users and ongoing geopolitical uncertainties. Sufficient inventory levels have prevented any significant price hikes, allowing the market to stabilize despite external pressures. Additionally, the prices of salicylic acid, a key raw material in aspirin production, have dropped, further easing production costs for manufacturers. Meanwhile, China's Purchasing Managers' Index (PMI) rebounded to 50.1, indicating a slight recovery in manufacturing activity. However, weak domestic demand during the 'Golden Week' holiday and a new export orders index of 47.3 have continued to put downward pressure on prices. The economic resilience of the U.S. is currently tempered by uncertainties surrounding the upcoming presidential election and persistent inflation concerns, which have led to cautious behavior among businesses. Looking ahead, ChemAnalyst predicts that aspirin prices may continue to decline, especially with the looming threat of potential 60% tariffs on imports from China, a policy reminiscent of former President Trump's trade strategies. This combination of factors underscores the complexities influencing the aspirin market and highlights the interconnectedness of global economic conditions. [660741cc]